Current Drug Discovery Technologies This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research

Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study
CONCLUSION: We propose two analogues of T6361 as new potential inhibitors of MurA enzyme. Their good ADME-Toxicity profile qualifies them to reach in vitro and in vivo assays as future lead molecules.PMID:37929742 | DOI:10.2174/0115701638244582231025110143 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Ilham Boulhissa Hanane Boucherit Abdelouahab Chikhi Abderrahmane Bensegueni Source Type: research